Avanafil CAS 330784-47-9
Model NO.:CAS 330784-47-9
Function: Specialist Drugs, Blood System Agents
Grade Standard: Medicine Grade
Origin: SZOB, China
Avanafil is a PDE5 inhibitor approved for erectile dysfunction by FDA on April 27, 2012 and by EMA on June 21, 2013.
Avanafil is known by the trademark names Stendra and Spedra.
Avanafil acts by inhibiting a specific phosphodiesterase type 5 enzyme which is found in various body tissues,
but primarily in the corpus cavernosum penis, as well as the retina. Other similar drugs are tadalafil and vardenafil.
The advantage of avanafil is that it has very fast onset of action compared with other PDE5 inhibitors.
It is absorbed quickly, reaching a maximum concentration in about 3045 minutes.
Azilsartan intermediates CAS 147403-03-0, CAS 147403-52-9
Linagliptin intermediates CAS 309956-78-3, CAS 666816-98-4, CAS 93703-24-3, CAS 93703-24-3
Silodosin intermediates CAS 160969-03-9, CAS 239463-85-5, CAS 175837-01-1
Avanafil intermediates CAS 41965-95-1, CAS 5909-24-0, CAS 23356-96-9, CAS 372118-67-7
Empagliflozin intermediates CAS 915095-86-2 , CAS 915095-87-3, CAS 915095-94-2, CAS 1279691-36-9
Parecoxib Sodium intermediates CAS 37928-17-9
Palbociclib intermediates CAS 571188-59-5, CAS 1016636-76-2
We are a manufacturer of Avanafil CAS 330784-47-9 and Avanafil intermediates for mens healthcare.
For more pls visit our web www.ok-biotech.com and contact us for your demands.